Sponsorship & Exhibition





Amgen oncologyAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be the world’s largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.


For more information, visit www.amgen.com and follow us on www.twitter.com/amgen



JanssenAt the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more at www.janssen.com/emea;Follow us at www.twitter.com/janssenEMEA




Bristol-Myers Squibb

Bristol-Myers SquibbSurgery, radiation, cytotoxic or targeted therapies have represented the mainstay of cancer treatment over the last several decades, but long-term survival and a positive quality of life have remained elusive for many patients with advanced disease.

To address this unmet medical need, Bristol-Myers Squibb is leading in an innovative field of cancer research and treatment known as Immuno-Oncology, which involves agents whose primary mechanism of action is to work directly with the body’s immune system to fight cancer. The company is exploring a variety of compounds and immunotherapeutic approaches for patients with different types of cancer, including researching the potential of combining Immuno-Oncology agents that target different pathways.

Bristol-Myers Squibb is committed to advancing the science of Immuno-Oncology, with the goal of changing survival expectations and the way patients live with cancer.








roche logo




Sponsors   Stand No.
Platinum Amgen No. 01
Janssen No. 16/17
Gold Bristol-Myers Squibb No. 07
Silver Ecancer No. 04
Pfizer No. 08
  Helsinn No. 02
  SAGE Publications
Exhibitors Stand No.
Beacon Hospital No. 22
CareFusion No. 14
Clinigen No. 20
EONS No. 15
European Association of Urology Nurses (EAUN) No. 19
HCA Healthcare UK No. 06
ICS (Irish Cancer Society) No. 25
IPOS No. 24
ISNCC No. 12
MASCC No. 23
ONS No. 11
Pamex No. 21
Paxman No. 03
Paxxo AB No. 13
PCM Scientific No. 18
RiceSteele Manufacturing No. 05
RIS Products No. 09


Exhibition Floor Plan